Purcell Richard David Jr. 4
4 · RespireRx Pharmaceuticals Inc. · Filed Aug 4, 2020
Insider Transaction Report
Form 4
Purcell Richard David Jr.
SVP - Research & Development
Transactions
- Award
Common Stock Options (to purchase shares of Common Stock)
2020-07-31+5,000,000→ 5,000,000 totalExercise: $0.01Exp: 2025-07-31→ Common Stock (5,000,000 underlying)
Footnotes (1)
- [F1]These Common Stock Options vest in four equal installments: 25 percent on July 31, 2020 (the grant date), 25 percent on September 30, 2020, 25 percent on December 31, 2020, and 25 percent on March 31, 2021.